Using PET 18F-FDG, 11CO, and 15O-water for monitoring prostate cancer during a phase II anti-angiogenic drug trial with thalidomide

K. A. Kurdziel, S. L. Bacharach, J. A. Carrasquillo, S. Huebsch, M. Whatley, D. Sellers, S. Steinberg, S. K. Libutti, J. Pluda, E. Reed, W. Dahut, W. D. Figg

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Using PET <sup>18</sup>F-FDG, <sup>11</sup>CO, and <sup>15</sup>O-water for monitoring prostate cancer during a phase II anti-angiogenic drug trial with thalidomide'. Together they form a unique fingerprint.

Medicine & Life Sciences